DexCom Inc/ US2521311074 /
2024-05-24 10:00:00 PM | Chg. +1.7700 | Volume | Bid10:00:00 AM | Ask10:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
127.3700USD | +1.41% | 2.28 mill. Turnover: 211.48 mill. |
127.0000Bid Size: 200 | 130.5000Ask Size: 200 | 50.65 bill.USD | - | 90.98 |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.